| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.2B | $1.0B | $1.1B | $1.1B | $1.1B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.6B | $0.5B | $0.4B | $0.5B | $0.5B | $0.4B | — |
| Net Income | $0.1B | $0.2B | $0.0B | $0.0B | $0.1B | $0.1B | $0.3B | $0.0B |
| EPS (Basic) | $0.98 | $1.62 | $0.33 | $0.38 | $0.95 | $0.81 | $1.85 | $0.17 |
| EPS (Diluted) | $0.95 | $1.58 | $0.32 | $0.37 | $0.93 | $0.80 | $1.84 | $0.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $38.8B | $37.9B | $35.1B | $33.3B | $36.2B | $35.3B | $33.6B | $31.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.7B |
| Total Liabilities | $36.2B | $35.4B | $32.9B | $31.9B | $30.9B | $29.9B | $29.0B | $28.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.6B | $2.5B | $2.2B | $1.4B | $5.3B | $5.5B | $4.7B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.6B | $0.5B | $0.6B | $0.7B | $0.7B | $0.3B |
| Investing Cash Flow | $-1.7B | $-1.5B | $-0.9B | $-1.8B | $-1.5B | $-0.6B | $-0.6B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.0B | $2.0B | $0.5B | $1.2B | $0.7B | $0.2B | $-0.1B | $0.1B |